Total Valuation
G Medical Innovations Holdings has a market cap or net worth of $260.00. The enterprise value is $3.60M.
Market Cap$260.00
Enterprise Value$3.60M
Share Statistics
G Medical Innovations Holdings has 259,918,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding259,918,180
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
G Medical Innovations Holdings’s return on equity (ROE) is 3.35 and return on invested capital (ROIC) is 892.01%.
Return on Equity (ROE)3.35
Return on Assets (ROA)-5.10
Return on Invested Capital (ROIC)892.01%
Return on Capital Employed (ROCE)5.16
Revenue Per Employee52.62K
Profits Per Employee-298.40K
Employee Count84
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of G Medical Innovations Holdings is ―. G Medical Innovations Holdings’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, G Medical Innovations Holdings had revenue of 4.42M and earned -24.63M in profits. Earnings per share was -34.17.
Revenue4.42M
Gross Profit784.00K
Operating Income-22.11M
Pretax Income-13.94M
Net Income-24.63M
EBITDA-8.65M
Earnings Per Share (EPS)-34.17
Cash Flow
In the last 12 months, operating cash flow was -26.76M and capital expenditures -2.34M, giving a free cash flow of -29.10M billion.
Operating Cash Flow-26.76M
Free Cash Flow-29.10M
Free Cash Flow per Share-0.11
Dividends & Yields
G Medical Innovations Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)50.39K
Important Dates
G Medical Innovations Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
G Medical Innovations Holdings as a current ratio of ―, with Debt / Equity ratio of -28.45%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA-0.21
Interest Coverage Ratio―
Taxes
In the past 12 months, G Medical Innovations Holdings has paid 16.00K in taxes.
Income Tax16.00K
Effective Tax Rate―
Enterprise Valuation
G Medical Innovations Holdings EV to EBITDA ratio is -0.48, with an EV/FCF ratio of -0.20.
EV to Sales0.94
EV to EBITDA-0.48
EV to Free Cash Flow-0.20
EV to Operating Cash Flow-0.23
Balance Sheet
G Medical Innovations Holdings has $1.51M in cash and marketable securities with $2.18M in debt, giving a net cash position of -$669.00K billion.
Cash & Marketable Securities$1.51M
Total Debt$2.18M
Net Cash-$669.00K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share―
Margins
Gross margin is 17.74%, with operating margin of ―, and net profit margin of ―.
Gross Margin17.74%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for G Medical Innovations Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―